Evidence map›Paper›PMID 21118998›Full record

ArticleMolecular biology of the cell2011

Telomeric recombination induced by dysfunctional telomeres.

Marie Eve Brault, Chantal Autexier

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Using telomeric chromosomal aberrations to evaluate clastogen-induced genomic instability in mammalian cells.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2020
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The potential utility of telomere-related markers for cancer diagnosis.Journal of cellular and molecular medicine · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marie Eve BraultDepartment of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada H3A 2B2.
Chantal Autexier
Jewish General Hospital · CA

Funding

Canadian Institutes of Health Research MOP-81215
6 · The paper itself

Abstract

Telomere maintenance is essential for cellular immortality, and most cancer cells maintain their telomeres through the enzyme telomerase. Telomeres and telomerase represent promising anticancer targets. However, 15% of cancer cells maintain their telomeres through alternative recombination-based mechanisms, and previous analyses showed that recombination-based telomere maintenance can be activated after telomerase inhibition. We determined whether telomeric recombination can also be promoted by telomere dysfunction. We report for the first time that telomeric recombination can be induced in human telomerase-positive cancer cells with dysfunctional telomeres.

Indexed as

Recombination, GeneticAtaxia Telangiectasia Mutated ProteinsBreast NeoplasmsCell Cycle ProteinsCell Line, TumorDNA-Binding ProteinsDNA, CircularFemaleHumansIn Situ Hybridization, FluorescenceIntracellular Signaling Peptides and ProteinsMutationProtein Serine-Threonine KinasesSister Chromatid ExchangeTelomeraseTelomereAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsDNA, CircularIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesTelomeraseTelomeric Repeat Binding Protein 1TP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Proteins

Identifiers

PMID21118998
PMCPMC3020914
OpenAlexW2098480715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.